Cystourethroscopes

Welcome to Cystourethroscopes Site
Cystourethroscopes Resources

Home > Cystourethroscopes > [Immunology] Role for {beta}-catenin and HOX transcription factors in Caenorhabditis elegans and mammalian host epithelial-pathogen interactions

[Immunology] Role for {beta}-catenin and HOX transcription factors in Caenorhabditis elegans and mammalian host epithelial-pathogen interactions




We used the model nematode Caenorhabditis elegans infected with the human pathogen Staphylococcus aureus to identify components of epithelial immunity....


Click Here to read the entire article...





Other Articles:


PTC Announces Data Showing That PTC124 Causes Statistically Significant Improvements In Chloride Channel Function In Cystic Fibrosis Patients
PTC Therapeutics, Inc. (PTC) announced that results from a randomized Phase 2a European study demonstrated that treatment with the investigational drug PTC124 caused statistically significant improvements in the chloride channel function of children with cystic fibrosis (CF) caused by a particular genetic mutation, called a nonsense mutation. Results from the study were presented today by Isabelle SermetGaudelus, M.D., Ph.D.
Click Here to read the entire article...
Listen to The Lancet: 20 September
Professor Richard Beasley discusses in a podcast results of the ISAAC-3 study, suggesting a strong association between paracetamol use in infancy and increased risk of asthma by age 6-7 years.
Click Here to read the entire article...
Fireworks
none
Click Here to read the entire article...
Click Here to read the entire article...
Medtech Startups, December 2007
New medical technologies represented in companies added (December 2007) to the Medtech Startups Database and/or added to the December 2007 issue of MedMarkets.

The following are brief technology descriptions for companies newly added to the MedMarket Diligence Medtech Startups Database and/or covered in MedMarkets Startups during the month of December:

  • EEG analysis for applications such as detection and prediction of seizure.
  • Drugs targeting inflammatory and metabolic pathways, including obesity, type 2 diabetes and cardiovascular disease.
  • In vivo transdifferentiation to regenerate ischemic or diseased organs.
  • Developing small molecule drugs to reprogram adult stem cells.
  • Orthopedic devices for pediatric and other small stature patients.
  • Devices and apparatus for insertion of flexible implants (e.g. breast implants, others).
  • Implantable devices; e.g., to prevent cerebrospinal fluid leaks.
  • Minimally invasive spinal instrumentation.
  • Intra-operative 3D imaging for earlier diagnosis of breast cancer.

Now Published!: Worldwide Wound Management 2007-2016. see link

For coverage in specific issues of MedMarkets, see link.

For details on the Medtech Startups Database, see link.

Tags: medtech, startup
Click Here to read the entire article...
Health Tip: After Your Child is Born (HealthDay)
HealthDay - (HealthDay News) - It's important to properly care for your newborn's umbilical cord to prevent infection and related complications.
Click Here to read the entire article...
Proceedings of the National Academy of Sciences
By info@mediligence.com - Copyright (c) 2008 Yahoo! Inc. All rights reserved. - version: v1.5 build A